Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jonathan L Yu"'
Autor:
Devin M. Mann, Javier Gonzalez, Jonathan L Yu, Son Luu, Danissa V Rodriguez, Katharine Lawrence, Dawn M Feldthouse
Publikováno v:
J Am Med Inform Assoc
Digital Diabetes Prevention Programs (dDPP) are novel mHealth applications that leverage digital features such as tracking and messaging to support behavior change for diabetes prevention. Despite their clinical effectiveness, long-term engagement to
Autor:
Ian I. Cardle, Jonathan L. Yu, Nataly Kacherovsky, Suzie H. Pun, Michael L. Baldwin, Stephen J. Salipante, Michael C. Jensen, Emmeline L Cheng
Publikováno v:
Nature Biomedical Engineering. 3:783-795
Chimeric antigen receptor T-cell therapies using defined product compositions require high-purity T-cell isolation systems that, unlike immunomagnetic positive enrichment, are inexpensive and leave no trace on the final cell product. Here, we show th
Autor:
Lisa L. Groom, Donna Shelley, Hayley M. Belli, Yinxiang Wu, Bonny Rockette-Wagner, Sumaiya Tasneem, Danissa V Rodriguez, Kathleen M. McTigue, Son Luu, Jerlisa Fontaine, Javier Gonzalez, Jonathan L Yu, Devin M. Mann, Katharine Lawrence, Dawn M Feldthouse
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 2, p e26750 (2021)
JMIR Research Protocols
JMIR Research Protocols
Background Digital diabetes prevention programs (dDPPs) are effective behavior change tools to prevent disease progression in patients at risk for diabetes. At present, these programs are poorly integrated into existing health information technology
Autor:
Katharine Lawrence, Danissa V Rodriguez, Dawn M Feldthouse, Donna Shelley, Jonathan L Yu, Hayley M Belli, Javier Gonzalez, Sumaiya Tasneem, Jerlisa Fontaine, Lisa L Groom, Son Luu, Yinxiang Wu, Kathleen M McTigue, Bonny Rockette-Wagner, Devin M Mann
BACKGROUND Digital diabetes prevention programs (dDPPs) are effective behavior change tools to prevent disease progression in patients at risk for diabetes. At present, these programs are poorly integrated into existing health information technology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3f51fd5f0bcafb16dec3147d404e8fe
https://doi.org/10.2196/preprints.26750
https://doi.org/10.2196/preprints.26750
Publikováno v:
Journal of Controlled Release. 282:140-147
The clinical success of chimeric antigen receptor (CAR) T cell immunotherapy in treating multiple blood cancers has created a need for efficient methods of ex vivo gene delivery to primary human T cells for cell engineering. Here, we synthesize and e
Autor:
Nataly, Kacherovsky, Ian I, Cardle, Emmeline L, Cheng, Jonathan L, Yu, Michael L, Baldwin, Stephen J, Salipante, Michael C, Jensen, Suzie H, Pun
Publikováno v:
Nature biomedical engineering
Chimeric antigen receptor (CAR) T-cell therapies using defined product compositions require high-purity T-cell isolation systems that, unlike immunomagnetic positive enrichment, are inexpensive and leave no trace on the final cell product. Here, we s
Autor:
Hua Cao, Maja Zavaljevski, Jingjing Tang, André Lieber, Elaine W. Raines, Maryelise Cieslewicz, Suzie H. Pun, Koka Motoyama, Jonathan L. Yu
Publikováno v:
Proceedings of the National Academy of Sciences. 110:15919-15924
Most current cancer therapies focus on killing malignant cells, but these cells are often genetically unstable and can become resistant to chemotherapy. Tumor-associated macrophages (TAMs) facilitate disease progression by promoting angiogenesis and